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1
S U M M A R Y

The N-ja-phenyl-(5-substituted-2-hydroxybenzylidene)J -amino acids react smoothly with amino
acyl polymers in the presence of N , N '-dicyclohexylcarbo
diimide (DCC) to afford the ketimine peptide resin
esters in quantitative yield.

Several N-protected

dipeptide resin esters were synthesized and
characterized as their methyl ester derivatives.

The ketimine protecting group was found to be
remarkably stable to hydrolysis when incorporated
into a Merrifield resin, in fact no suitable method
for its removal from peptide resins could be
developed.

This unusual stability of the

diarylmethylene protecting group when incorporated
into a Merrifield type styrene divinylbenzene
polymer support suggested its suitability for the
side chain protection of ornithine and lysine in
solid phase peptide synthesis.

The Na-t-butyloxycarbonyl-Ne-Ja-phenyl(5-substituted-2-hydroxybenzylidene)]-L-lysine and
ornithine have been synthesized and coupled with
valine or alanine resins to form N-protected
peptide resin esters.

The ketimine protecting

group was stable under anhydrous acidic conditions
and the urethane blocking group could be removed

.

s

- 2 -

preferentially from the ot-amino function.

Several

lysine and ornithine containing tetrapeptides
have been synthesized by the solid phase technique.

' I N T R O D U C T I O N

3
A.

GENERAL INTRODUCTION

The synthesis of peptides is important
for an understanding of protein function and where
the biological activity of peptides resides.

The

first successful synthesis of a dipeptide was due
to Fischer1, who introduced a method of simultaneous
carboxyl activation and amino protection.

He

synthesized 2,5-diketopiperazine (1) which could
be hydrolyzed to yield the free dipeptide.

This

route is only applicable for the preparation of
dipeptides.

Immediately following Fischer!s

publications, Curtius2 , developed a general
synthetic route for the preparation of peptides.
In this procedure, acyl amino acid esters were
converted to the corresponding hydrazides, which
on treatment with nitrous acid gave the reactive
azides.

The synthetic route is shown in Fig (2).

The azides are good acylating agents and they react
with the free amino group of a second amino acid
to yield the acyl dipeptides.
can be extended for the
chain peptides.

The azide method

preparation of longer

In recent years, the synthesis of

physiologically active peptides has become a reality
3
and recently the first partially active enzyme has
been synthesized.

H

H
R -Ô ------ C 30
/

\

H -N

N-H

A

(1 )

X N H -C H R -C O O R 1 + H2N-NH2

---------»

XNH-CHR-CONHNH2

XNH-CHR-CONHNH

--------- >

X N H -C H R -C O N ,

xnh- ch r- con 3

+ HONO

+

H2N -C H R ’ '-C O O Y

XN H -CH R -CO N H -CH R ' '-C O O Y

(2 )

5
The synthesis of a peptide requires the
formation of an amide bond through acylation of
the amino group of one amino acid (1 ) by a second
amino acid (11).

h

Fig (3).

2n - c h r -c o o h

+

(I)

H 2N-CHR-CONH-CHR -COOH

(3)

Since each amino acid contains at least one amino
and one carboxyl group, they both can act as
acylating agents or as the amino acids to be
acylated.

Therefore, such a reaction can lead to

at least three different dipeptides.

Since only

one peptide product is desired, it is necessary to
protect the amino group of (I) and the carboxyl
group of (II).

Similarly, all other functional

group of any polyfunctional amino acid, such as
glutamic acid and lysine, which are to be
incorporated into the peptide chain must be
protected.

6
In the synthesis of a polypeptide, two
broad types of protecting groups are required, one
which intermittently protects amino and carboxyl
groups and liberates them selectively and a
second type which permanently blocks other reactive
functional groups.

All of these protecting groups

must finally be capable of removal under conditions
which do not damage the sensitive peptide product.
Since most peptides are stable under mild, acidic
conditions, it is most convenient to choose
combinations of protecting groups which can be
selectively removed under acidic conditions.

The most extensively used protecting
groups in peptide synthesis are those based on
benzyl and t-butyl residues.

For amino protection

these residues are used in the form of the
benzyloxycarbonyl (Z) (Ha) and the t-butyloxycarbonyl
5 56

(Boc)

(Hb) groups.

Their counterparts for
7

carboxyl group protection are the benzyl (Bzl)

(Ha)

(Hb)

(He)

7

Uc)

(4d)

The benzyloxycarbonyl (Z), which was

k
first introduced in 1932 by Bergmann and Zervas

,

is extremely useful for the protection of amino
groups.

The Z-derivatives,of amino acids are

readily prepared, are stable, and the protecting
group can be easily removed without
of the peptide bond.

hydrolysis

The N-protected amino acid

derivatives can be easily prepared by reaction
of the amino acid with carbobenzoxy chloride in
slightly alkaline conditions.

The Z-protecting

group can be removed by a variety of methods,
such as, hydrogenolysis, reduction with sodium
in liquid ammonia or with hydrogen bromide in
acetic acid.

The t-butyloxycarbonyl (Boc) group,
which was introduced simultaneously by Me Kay 8

5

Albertson

6

and Anderson 8 Me Gregor

in 1957,

has

8
proved to be an even more useful protecting group.
The Boc-amino acid derivatives can be prepared by
9
the Schnabel method , which involves a reaction of
the amino acid with Boc-azide at pH 9.8.

Alternatively,

it can also be prepared by the procedure known as
1o
the Schwyzer method , which involves a reaction
of the amino acid, Boc-azide in the presence of
o

magnesium oxide at H0-50 C for 20 hours.

The

cleavage of the Boc group can be carried out with
50% trifluoroacetic acid in dichloromethane at
room temperature.

Within a short time, complete

removal of the Boc group can be achieved.

The

Boc—amino acid derivatives are now commercially
available and are the most popular starting materials
for peptide synthesis.

Since the benzyl and t-butyl residues
are each selectively removable in the presence of
the other, it is possible to use one type of residue
as a means of intermittent protection while the
other type is used to mask side chain functions
throughout the synthesis.
polyfunctional

The presence of

amino acids such as lysine and

glutamic acid introduces a number of restrictions
in the selection of the remaining protecting groups
and their subsequent removal.

With diamino-

monocarboxylic.acids such as lysine and ornithine,

- 9 the protecting group used for the side chain amino
function must remain attached during the condensation
and deblocking processes.

It is therefore necessary

to introduce another type of a- amino protecting
group which can be selectively removed in the
presence of other side chain blocking group. The
11
o-nitrophenylsulphenyl (Nps)
and 2-(p-biphenyl)12
isopropyloxycarbonyl (Bpoc)
are most suitable for
this purpose.

Since the Nps group is extremely

sensitive to acids and can be cleaved selectively
in the presence of a carbobenzoxy group, it has
been used for a-amino protection of lysine and
ornithine.

Another acid labile blocking group worthy
13
of mention is the triphenylmethyl (trityl) residue ,
which can be cleaved without the removal of the Boc
group.

Dilute acetic acid at room temperature will

remove the trityl group completely.

The use of

an acid labile protecting group is advantageous for
a lengthening of a peptide chain which includes
amino acids bearing functional group in their side
chain.

The use of Schiff base derivatives of
amino acids as a means of acid labile a-amino group
protection for the synthesis of peptides has

10
also been reported.

There are a number of- methods

used for the preparation of Schiff base derivatives
of amino acids.

Mclntire investigated the reaction

of a number of aromatic aldehydes with free amino
acids.

Of the several different aromatic aldehydes

examined for Schiff base formation, only the
o-hydroxyaldehyde yielded Schiff bases which could
1^
be isolated
. Crystalline amino acid derivatives
of 5-chlorosalicylaldehyde (5a) and 2-hydroxy-lnapthalaldehyde (5b) have been prepared.

The increased stability of these o-phenolic aldehyde
derivatives was attributed to the formation of
strong intramolecular hydrogen bond between the
1 5

phenolic proton and the imine nitrogen atom

.

The compounds were later used by Sheehan

16
and Grenda

in peptide synthesis but only some

N-terminal valine dipeptide esters were prepared.

11
. Hope and Halpern

1 7
reported a new method

for preparation of sterically pure crystalline
derivatives of o-hydroxy substituted aromatic ketones
with free amino acids.

In this method, amino acids

were first converted to their tétraméthylammonium
salts which are condensed with o-hydroxy aromatic
ketones in anhydrous medium in the presence of
molecular sieve.

The new approach is superior

to Me.IntireTs method as the tétraméthylammonium
salts of amino acid are more soluble in alcoholic
solvents than the respective sodium and potassium
salts and thus the condensation reaction is faster
and proceeds to completion at room temperature.
The ketimine derivatives can usually be isolated as
the free acids by careful acidification of the
tétraméthylammonium salts.

The new synthetic route

is outlined schematically in fig (6)

The o-hydroxy aromatic ketones could be
condensed with all the protein amino acids, except
proline, to yield yellow crystalline optically
18
pure ketimine derivatives . The two most useful
o-hydroxy aromatic ketones for this reaction are
5-chloro-2-hydroxybenzophenone (7) and 2-hydroxy5-methylbenzophenone (8)

All these ketimine derivatives are shown

12

-

+ ! -

H 3N-CHR-C00 +

+

(CH3)4N j O H ----» H 2N-CHR-COO N(CH3 )l+
+

H 20

(I)
R'
(I)

+

\.c=o

- t
C =N-CHR-COO N (CH0)„

R\
»

\C=N-CHR-COOH
OH

R

(6 )

13
to have an ultraviolet absorption near 220 nm
(log

e

about 4) which is

indicative of an

19

azomethine bond

* and they showed bands in the

infrared near 1715 and 1610 cm“1 which can be
assigned to the imine function
magnetic resonance (p.m.r)

^C=N.

The proton

spectrum of glycine

and alanine derivatives confirmed the Schiff base
formulât ion (9)

Ph

\c=o

R = CgHj- , R' = Cl (7)

R = Cg H&, R'

= CH,

( 8)

Ph

\C=N-CHR-C00H
R = C cH c
b d

R ’ 1 = Cl or CH3
(9)
The postulated structure of (9) was also confirmed
by Electron Impact Hass Spectrometry as (9) gave
rise to a characteristic ion (10 ) which is formed
by the loss of 44 mass unit (CC^) from the molecular
ion.

This ion (10) can be conveniently used to

14
identify the particular amino acid.

\

C=N-CH„R

(1 0 )

OH

The N-(2-hydroxyarylmethylene) amino
acids are soluble in most organic solvents and are
stable under the condition commonly used in peptide
synthesis.

The increased stability of these

derivatives may be due to the presence of the
o-hydroxy group in the aromatic ketones and the
resulting hydrogen bonding prevents the cleavage of
the imine bond during the peptide bond formation.

Racemization of optically active amino
acids protected by the diarylmethylene system is
not possible through the classical azlactonization
2 0)21

mechanism

generally proposed for N-acylated

amino acids, although other base catalysed
mechanisms for racemizatioh can be postulated.
The steric purity of these derivatives has been
confirmed by gas liquid chromatographic (g.l.c)
analysis of

diastereoisomeric amino acid
22

derivatives

..

15
The main advantages associated with the use of
ketimine derivatives are, firstly, their convenient
solubility in many organic solvents commonly used
for the peptide coupling reaction.

Secondly, the

ketimine derivatives can be readily condensed by
the use of coupling reagent such as N,N'-dicyclohexyl2 3
carbodiimide (DCC) without the danger of
racemization.

Thirdly, the ketimine derivatives

of amino acids and peptides are coloured and thus
are readily detected in most chromatographic
purification procedures.

16
B.

INTRODUCTION TO SOLID PHASE PEPTIDE SYNTHESIS.
2

%

52 5

In 1962, Merrifield

developed a new

approach to the chemical synthesis of polypeptides.
In this method, the carboxyl terminal amino acid of the
peptide to be~ synthesized, is covalently linked to
an insoluble solid support, and the peptide is built
up by stepwise addition of amino acids from the
carboxyl end according to the scheme in (11)

The solid support is a chloromethylated
polystyrene-divinylbenzene resin (1).

The

chloromethyl groups of the resin can be reacted with
the carboxyl group of the N-protected amino acid
to form an amino acyl resin (2).

The protecting

group, Y, must be sufficiently labile so that it
can be selectively removed without damage to the
ester bond linking the amino acid to the polymer.
After removal of the protecting group, a second
N-protected amino acid (3) may be coupled to the
^mino acid resin to form the N-protected dipeptide
resin (H).

The deprotection and coupling steps

may be repeated using the next N-protected amino
acid until the desired sequence assembled to the
polymer support.

At the end of the synthesis, the

finished peptide is cleaved from the resin using
26

an appropriate reagent such as hydrogen fluoride

.

17

XNH-CHR '-COOH

+

Y-jPolymep)

Q)

1

XNH - C H R 1-COO-|PÔÎÿmëri

(2)

deprotect

*
XNH-CHR"-CO OH + H^N-CHR '-COO-lPolvm'ërl

couple

XNH-CHR"-CONH-CHR'-COO-|PÔlvmer|

cleave

H 2N-CHR"-CONH-CHR'-COOH + IPolymer

(11)

(n)

(3)
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Since the peptide product is always insoluble
in the solvents used for the synthesis, the
intermediate and final products can be readily
recovered by a simple filtration.

Since the whole

synthesis can be carried out in a single reaction
vessel, losses due to repeated transfer of material
are avoided.

The reaction must be forced to completion

at each step in order to obtain a homogeneous
product, and this is usually done by the use of excess
reactants and long reaction times.

Peptide synthesis

by the Merrifield procedure are considerably faster
than the classical route and better yields are
generally obtained.

The Merrifield technique has

been used to synthesize a wide range of peptides
containing all the protein amino acids. The largest
peptides synthesized by this method so far are
27
20
insulin and ferredoxin .

An automated solid phase synthesizer
which can attach up to six amino acid residues to
2 9)30
the resin per day has been developed
.

The Boc-amino acids are the most
preferred amino acid derivatives for solid phase
synthesis and they can be satisfactorily attached
to the chloromethylated resin.

The coupling reagents

most commonly employed in solid phase synthesis are
31
32)33
the oarbodiimides and the active esters
.

19
The N,N*-dicyclohexylcarbodiimide is commercially
availablej inexpensive, and convenient to use.
Active esters, such as p-nitrophenyl esters have also
been used for the synthesis of several large peptides,
3 k
such as insulin .

The ease of removal of the diarylmethylene
protecting group by dilute acid suggested its use
for the a-amino protection in solid phase peptide
synthesis and this is the subject of this work.

,

D I S C U S S I O N

20
Application of ketimine derivatives of Amino Acids
in Solid Phase Peptide Synthesis,

The N- j*a-phenyl-( 5-chloro-2-^hydroxybenzylidene)]

(Abbr. 5-C1B) and N-[a-phenyl-(2-

hydroxy-5-methylbenzylidene)] (Abbr. 5-MeB) amino
acid derivatives have been reacted with a Merrifield
type styrene divinylbenzene support yielding the
corresponding N-protected amino acyl resins.
Several of these ketimine amino acyl resins were
prepared using the standard esterification
3 5)36

procedures

, in which the N-ketimine amino acid

derivatives and the resin were refluxed with stirring in
absolute ethanol in the presence of triethylamine
for forty eight hours.

The amino acid content of

.

the resin was determined, by direct mass spectroscopy
In this method, the ketimine amino acid resin
hydrolyzed with 6 N

was

HC1 and transferred to a

micro reaction vial with a known amount of stable
isotopically labelled amino acid internal standard.
The free amino acids were then converted to N-acetyl
amino acid methyl ester derivatives for mass
spectrometric/analysis. The amino acid content of
the resins were comparable with those obtainable
with Boc-amino acids using the same published
conditions.

See table (12)

37

.

21
Amino Acid content of chloromethyl resin using Boc amino acid and ketimine amino acid derivatives.
Table

(12)

Amino Acid content in 1 gram of Resin of
Boc-A.A-Resin Esters

0.2H

Valine

0.32

Leucine

0.36

•

o

Alanine

S ÌCO

Glycine

Ketimine-A.A-Resin Esters

mmole

0.30

5 5

0.27

5 5

>

5

0.32

5 5

5

»

0.29

5

mmole

>

Although the diarymethylene protecting
group is removed with relative ease from N-protected
17
peptide methyl ester with dilute acid , it is
remarkably stabilized when incorporated into the
Merrifield type resin support.

This was shown by

f

taking a portion of 5-ClB-L-alanyl-resin ester (0.5 g)
and treating it with 80% acetic acid at room
temperature for six hours, the resin still retained
the yellow colour and only a trace of ketone was
detectable in the mother liquor.

A further portion

was treated with trifluoroacetic acid in dichloromethane for 30 minutes and the colour of the resin
was still bright yellow which indicated that the
ketimine amino acid was still attached to the resin.
The thin layer chromatogram of the extract showed
no evidence of cleavage of the diarylmethylene group.

22
A satisfactory method for removal of the
diarylmethylene group from amino acyl resins
without hydrolysis of the amino acid-resin bond
has not been found.

To demonstrate further the

stability of the diarylmethylene group

when

attached to an amino acid resin we prepared 5-C1Bglycyl-L-phenylalanyl-resin ester using N,N'-dicyclo
hexyl car bod iimide' (DCC)

as the coupling agent.

Treatment of the resulting ketimine peptide
resin with aqueous acetic acid or aqueous hydrogen
chloride (4N) did not remove the yellow colour.
T.l.c of the extract showed no evidence of
cleavage of the diarylmethylene group.

The

presence of 5-ClB-glycyl-L-phenylalanine methyl
ester on the resin was confirmed by transesterification
with methanol in the presence of triethylamine
followed by C.I mass spectrometry of the product.
This showed a molecular ion m/e 451 (MH+).

The

recovered material was shown to be identical by
t.l.c and mixed melting point with authentic
5-ClB-glycyl-L-phenylalanine methyl ester prepared
by condensation of 5-ClB-glycine with L-phenylalanine
methyl ester in solution.

This surprising stability

of the ketimine function was confirmed with a
number of other ketimine peptide resins and in all
cases the ketimine peptide methyl ester could be
recovered unchanged by transesterification.

23
This increased stability of the ketimine
amino ac'id resin esters may be due to an inability
of the water needed for the hydrolysis to
penetrate the resin beads.

Also, it has been

shown that the peptide chain are contained within
the pores of the beads

(13).

This suggested

that ketimine dipeptide acyl resin should be stable
under anhydrous acid conditions such as treatment
with trifluoroacetic acid:dichloromethane (1:1).
This was shown to be so and no evidence of
hydrolysis of the diarylmethylene function was
detected by t.l.c.

A satisfactory method for

the removal of the diarylmethylene protecting
group from the amino or peptide acyl resin
without hydrolysis of the amino acid-resin bond
has not been found to date.

Thus, the approach

of using this group for a-amino protection in
solid phase synthesis

was obviously not feasible.

However, the remarkable stability of the diarylmethylene
group when incorporated into a Merrifield type
resin suggested that the protecting group might
be suitable for side chain protection of amino
functions in solid phase peptide synthesis.

In the synthesis of peptides containing lysine
or

ornithine residues, it is necessary to

protect the e-amino group permanently during

(1 3 )

the synthesis.

When the t-butyloxycarbonyl (Boc)

is used for the protection of the a-amino

.

function, the side chain protecting group must
remain intact during acidolysis of the Bocgroups.

Up to now the carbobenzoxy (Z) group

has been used for this purpose, but it has been
shown recently this causes difficulties, because
acidolytic deprotection of the Na-Boc group
brings about some cleavage of the Z-protecting
38,39
group
. The loss of some of the N protecting group from a lysine residue during the
deprotection of the Na-Boc group will generate
a free e-amino group which can couple with an
activated amino acid to form a branched peptide
chain.

This can be a serious problem; for

example in a recent synthesis of a deca-lysylvaline peptide, the product was shown to contain
some 30% of unwanted branched chain peptides

.

We have now investigated the application
of the diarymethylene group for side chain
protection of ornithine and lysine in solid
phase synthesis.

To test this approach it was

necessary to synthesize the N -Boc-N -5MeB~Llysine (14) and Na-Boc-N^-5ClB-L-ornithine (15)
derivatives for use in solid phase peptide
synthesis.

These derivatives could be prepared by

25
a condensation reaction of 2-hydroxy-5-methylbenzophenone and 5-chloro-2-hydroxybenzophenone
with the tetramethylammonium salts of N tt-Boc-L.
cx
lysine and N -Boc-L-ornithine.
.

Ph

\
C=N-(CH2 )1+-CH(NHCOOC(CH3 )3COOH
OH

(14)

Ph

\C=N-(CH2 )3-CH(NHCOOC(CH3)3COOH
.OH

C l ^ ^

(15)

The resulting ketimine dérivatives could be isolated
as the free acids by a careful acidification of
the tetramethylammonium salts to a pH between 5-6,
Both ketimine derivatives showed bands in the

-26 infrared region near 1715 cm~^ and 1610 cm~^.
Their structure was confirmed by C.I mass
spectrometry of the products which yielded molecular
ion at m/e 396 (MH+-C00H) for Na-Boc-Ne-5MeB-Llysine (14) and m/e 402 (MH+-C00H) for I^-Boc-N65ClB-L-ornithine (15).

The compound (14) and (15)

could be coupled with valine and alanine resins
respectively to yield the Na-Boc-Ne-5MeB-L-lysylL-valine resin ester (16) and the I^-Boc-N^-SCIBL-ornithyl-L-alanine resin ester (18).

The

presence.of these peptides on the resins could
be confirmed by a treatment with triethylamine*♦2
methanol
which yielded the corresponding methyl
esters.

The C.I mass spectrometry of these

derivatives gave molecular ion at m/e 554 (MH+)
for Na-Boc-Ne-5MeB-L-lysyl-L-valine methyl ester
(17) and m/e 532 (MH+ ) for Na-Boc-N6-5ClB-Lornithyl-L-alanine methyl ester (19).

The Boc-

group of the respective resin esters (16,18)
could be removed by 30 minutes treatment with
trifluoroacetic acid-dichloromethane (1:1).

The

diarylmethylene group remained intact under these
conditions as the resins retained their bright
yellow colour during the Boc deprotection step.
The free dipeptide resin esters were then treated
with an excess of Boc-glycine in dichloromethane
and the N,N'-dicyclohexylcarbodiimide coupling
reagent.

27

Ph

\

C=N( CH2 ) ^CH (NHCOOC ( CH3 ) 3 ) CONHCHR]LCOY
OH
(16)

Triethylamine/MeOH

Ph
\

C=N(CH2 ) 1+CH(NHCOOC(CH3 ) 3 )CONHCHR1COOCH3
OH

(17)

R±

= CH-(CH3 )2

Y

= O-Polymer

Ph

VC=N(CH„),CH(NHCOOC(CH,).)CONHCHR„COY
‘

2 3

3 3

2

OH

(18)

Cl

Triethylamine/MeOH

Ph

\.C=N(CH2 )3CH(NHCOOC (CH3 )

)CONHCHR2COOCH3

OH

Cl

(19)

R2 = CH3
Y

- O-Polymer
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After 2^ hours at room temperature, the excess reagent
was removed by washing the resin with a suitable
solvent.

The presence of tripeptides on the resins

were confirmed by a transesterification with
triethylamine-methanol.
In both cases, Boc-glycyl£
N -5MeB-L-lysyl-L-valine methyl ester (20) and Bocglycyl-N -5ClB-L,-ornithyl-L-alanine-methyl ester (21)
were obtained in good yield.

The identities of

these compounds were established by t.l.c; amino
acid analysis; and C.I mass spectrometry, m/e 611
(MH ) and.m/e 589 (MH+ ) respectively.

A flow

chart o f •these syntheses is shown in fig (22)

(c h 3 )3c o c o n h c h 2c o n h c h c o n h c h r ’c o y
R ’ = CH(CH3)2
Y

- 0-Polymer

(CH0 )oC0C0NHCHoC0NHCHC0NHCHR”C0Y
3 3
2

w
N

RM

3

OH

Y

Cl
(21)

CH
= 0-Polymer
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£
N-5MeB

H

Boc
£
N-5MeB

OH
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Boc

Resin

N-5MeB
Boc

OH

H

NH2 ^

Resin

DCC
Boc

N -5 M e B ^

Resin

£
N-5MeB

Et3N/MeOH
OCH.

Boc

, (22)
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In order to test the suitability of the
diarylmethylene protecting group for e-amino group
protection, we also synthesized tetrapeptides
containing lysine and ornithine using the scheme
outlined in fig (23) .

In all these syntheses, the

t-butyloxycarbonyl (Boc) function was used for
a-amino group protection and in all cases the
coupling reaction was carried out with
hexylcarbodiimide

N,N’- dicyclo-

(DCC) in dichloromethane.

After peptide condensation the byproduct of the
reaction U , N 1-dicyclohexylurea was removed by
washing the resin esters with methanol and ethanol.
In this synthesis, the Boc-L-valine resin ester
and Boc-L-alanine resin ester starting materials
were deprotected with trifluoroacetic acid:
dichloromethane (1:1).

After each deprotection

step, the resin effluent was checked for any
evidence of ketone in the washings by concentrating
the solution and running the residue on t.l.c
(benzene).

In all cases, no indication of any

ketone could be found.

The resulting tetrapeptide

resin esters were shown to homogeneous by
conversion to their methyl ester derivatives
\

(triethylamine-methanol) followed by t.l.c.
These compounds were readily detected on the
chromatogram due to their yellow colour.

To

establish the presence of peptides and amino acid
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derivatives without the side ketimine group in the
transesterification products, the chromatogram were
«♦ 3

also sprayed with a hypochlorite- o-tolidine spray

.

This is used for visualizing peptide bond compounds.
Again no unprotected peptide products could be
detected.

The amino acid contentof the tetrapeptides

was confirmed by acid hydrolysis followed by
37

direct C.I mass spectrometry

.

In this method, the

amino acid mixtures obtained from the hydrolysis of
the peptide were transferred to a micro reaction
vial and a known amount of deuterium or
amino acid internal standard was

added.

N labelled
The

solutions were then evaporated to dryness under

a

^stream of nitrogen and treated with acetic anhydride
methanol which converts the amino acids to their
N-acetyl amino acid methyl ester derivatives.

The

solutions were then transferred into capillary
tubes, evaporated to dryness, and admitted through the
insertion probe for direct spectrometric analysis.
The amino acid analysis of the product glycylglycyllysylvaline were found to be gly 2.08, lys 0.96, and
val 1.00 and for glycylglycylornithylalanine were
shown to be gly 1.96, and ala 1.00.

Ornithine

was not determined because no isotopically labelled
standard was available.

. Our results suggest that the
diarylmethylene protecting groups are suitable for
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(23)
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(23 )
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side chain

protection of lysine and ornithine in

solid phase synthesis and that the method has
distinct advantages over the conventional^carbobenzoxy
derivatives

of lysine and ornithine.

E X P E R I M E N T A L
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GENERAL

Melting points were determined using a
Reichert hot-stage microscope and are uncorrected.
All the temperatures are expressed in degrees
Celcius.

Optical rotations were measured on a
Carl Zeiss circle .01 manual polarimeter using a
0.5 dm tube.

Infrared spectra were recorded on a
Perkin Elmer 357 grating spectrophotometer.

P.m.r

spectra were determined using a Jeolco JNM-4H-100
machine with tetramethylsilane as internal
reference.

Mass spectra were obtained from a Du Pont
21-491B instrument.

Microanalysis were performed by Dr. E.
Challen of the University of New South Wales and
by the Australian Microanalytical Service, CSIRO,
Melbourne.

Column chromatography of peptide
derivatives was carried using Merck silica gel.

36Thin layer charomatography (t-.l.c) was performed
with Merck silica gel G (0.025** layers). Rf
values should be taken as a guide only.

Schiff base

derivatives could be visualized directly or by
exposure to iodine vapour.

Peptide bonds were

detected by the hypochlorite-o-tolidine method
and the free amino groups were detected with
ninhydrin.

Light petroleum refers to the fraction
b.p. 60-80 C.

Combined organic phases from extracts
were dried with anhydrous magnesium sulphate.

Anhydrous solvents were employed in
condensation, coupling and recrystallization steps
involving the Schiff bases.

Molecular sieve type 3A (1/16** pellets)
was manufactured by the Linde Air Products Co.
and distributed by BDH Chemicals (Poole, England)

Amino acids and amino acid derivatives
used in the condensation were supplied by Fluka
(Buchs, Switzerland), Bachem Inc. (Marina Del Rey,
California), Sigma Chemical Co. (St Louis,
Missouri and BDH Chemicals (Poole, England).

37
The ketones were obtained from Pfaltz
and Bauer (Flushing, New York).

The Boc amino acyl resins used for
Solid phase synthesis were purchased from Schwarz
Mann (Orangeburg, New York).

Merrifield resin was

supplied by the Pierce Chemical Co. (Rockford,
Illinois).

38
Preparation of Amino Acid Methyl Ester Hydrochlorides.

Methyl esters of glycine and phenyl
alanine were prepared by the method of Brenner and
Huber

H

To dried methanol

5
cooled in dry

ice-acetone was added freshly distilled thionyl
chloride (0.7 ml). The amino acid (1 g) was then
refluxed for H5 minutes with the methylsulphonyl
chloride reagent.

After evaporation of the

solvent, the crystalline residue was twice
redissolved in alcohol and again evaporated and
the ester hydrochloride was finally recrystallized
from methanol-ether mixture.

Preparation of Tétraméthylammonium Hydroxide
Solution.

A mixture of tétraméthylammonium
bromide (6.16 g, 40 mmole) and silver oxide
(7.0 g, 30 mmole) was stirred for 1 hour in methanol
(70 ml), then filtered.

The filtrate was diluted

to 100 ml with methanol and the correct strength
of the base (approximately 0.4 mmole/ml) was then
determined by titration of an aliquot with standard
sulphuric acid solution using phenolphthalein as

39
an indicator. The solution can be kept
.
o
satisfactorily when stored at 0 C over molecular
sieves (3A).

Preparation of Dicyclohexylamine Solution.

Freshly distilled dicyclohexylamine
(7.96 ml, 40 mmole) was diluted to 100 ml with
methanol and stored over 3A molecular sieves
o
.
at 0 C. The strength of the solution (approximately
0.4 mmole/ml) was determined by titration of an
aliquot with standard hydrochloric acid using
bromocresol green-methyl orange (5:1) mixed
indicator

A.

.

General Procedure for the preparation of

N- [a-phenyl-(5-substituted-2-hydroxybenzylidene)]
Amino Acids.

A mixture of the amino acid ( 3 mmole),
tétraméthylammonium hydroxide solution ( 3 mmole)
and the appropriate ketone ( 3 mmole) was diluted
with methanol ( 20 ml) and the mixture was kept
over molecular sieves (3A) until a homogeneous
solution resulted ( from 1 to 10 days).

After

removal of the solvent on a rotary evaporator,
water (40 ml) was added and the unreacted ketone

40
starting material was filtered off.

The pH of the

filtrate was then adjusted to between 5-6 by
careful addition of 20% citric acid solution and
the Schiff base was extracted into ethyl acetate
ether (9:1) solution. The dried residue was
recrystallized using ethyl acetate and light
petroleum ether.

Preparation of N- [a- phenyl-(5-chloro-2-hydroxybenzylidene)

-glycine (I)

Glycine (225 mg, 3 mmole), tétraméthyl
ammonium hydroxide (2.46 ml/mmole, 3mmole) and
5-chloro-2-hydroxybenzophenone (698 mg, 3 mmole)
were diluted with methanol ( 20 ml) and the
reaction mixture was kept over a few sticks of
molecular sieves (3A) for several days until a
homogeneous solution resulted.

The mixture was

worked up as described in A. Yield 564 mg (65%);
°
+
m.p 158-160 C; mass spectrum m/e 245 (MH -C00H);
Found C, 61.8; H, 4.4; N, 4.8.

Ci5H12C1N03

requires C, 62.2; H,4.1; N, 4.8 %.

Preparation of N- [ot-phenyl-(5-chloro-2-hydroxybenzylidene)J

-L-alanine (II).

L-alanine (267.3 mg, 3 mmole),
tétraméthylammonium hydroxide (2.46 ml/mmole, 3 mmole)

and 5-chloro-2-hydroxybenzophenone (698 mg, 3 mmole)
were diluted with methanol ( 20 ml) and the
reaction mixture was kept over a few sticks of
molecular sieves (3A) for several days until a
homogeneous solution resulted.

The mixture was

worked up as described in (A).

Yield 645 mg (71%);

m.p 180-182 C; (a)^-24 (c 4, methanol); mass
spectrum m/e 259(MH+-COOH); Found C, 63.0; H, 4.7;
N, 4.5. 'c16HllfClN03 requires C, 63.3; H,4.6; N, 4.6%.

Preparation of N- fcct-phenyl-(5—chloro-2—hydroxybenzyl idene)J -L-valine (III)

L-valine (351.5 mg, 3 mmole), tetraméthylammonium hydroxide (2.46 ml/mmole, 3 mmole)
and 5-chloro-2-hydroxybenzophenone ( 698 mg, 3 mmole)
were diluted with methanol 20 ml and the reaction
mixture was kept over a few sticks of molecular
sieves (3A) for a few days until a homogeneous
solution resulted.
desribed in (A).
(gO j^-52

The mixture was worked up as
o
Yield 526 mg(53%); m.p. 145-146 C;

; mass spectrum m/e 287 (MH+-C00H) ; Found

C, 65.3; H, 5.5; N,4.4.

^gH^gClNO^ reclu^res C,

65.2; H, 5.5; N, 4.2 %.

Preparation of N- [ot-phenyl-(2-hydroxy-5-methylbenzylidene)] -L-leucine (IV).
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L-leucine (393.5 mg, 3 mmole), tetramethylammnium hydroxide (2.46 ml/mmole, 3 mmole)
and 2-hydroxy-5-methylbenzophenone (636 mg,
3 mmole) were diluted with methanol ( 20 ml) and
the reaction mixture was kept over a few sticks
of molecular sieves (3A) for several days until
a homogeneous solution resulted.
worked up as described in (A).

The mixture was
Yield 487.5 mg

(50%);m.p 128-130 C; (a)^ -88 (c 0.5, methanol);
mass spectrum m/e 281 (MH+-C00H); Found C, 73.7;
H, 7.1; N, 4.6.

^20^23^3 reQuires C? 73.8;

H, 7.1; N, 4.3 %.

Preparation of Na-t-butyloxycarbonvl-N£-[ctphenyl-(5-chloro-2-hydroxvbenzvlidene)1 -L-lysine (V).

Na-Boc-L-lysine (741 mg, 3 mmole),
tétraméthylammonium hydroxide (3 mmole) and 5chloro-2-hydroxybenzophenone (698 mg, 3 mmole)
were mixed and diluted with methanol (20 ml). After
leaving over molecular sieves (3A) for several
days, the mixture was worked up as described in
(A).

The ethyl acetate-ether extract yielded the

free acid derivative as a yellow hygroscopic foam.
V
(chloroform) 3450, 1690 (urethane), 1720 (acid)
max
and 1610 (imine) cm” .
(MH+-C00H).

Hass spectrum m/e 416

The free acid derivative was

unstable and was converted

to its dicyclohexylamine

salt by treatment with a freshly distilled
dicyclohexylamine solution (0.4 mmole/ml).

The

yellow crystalline solid was recrystallized
several times from ethyl acetate but a satifactory
analysis could not be obtained.

The yield was

51%.

Preparation of Na-t-butyloxycarbonyl-Ne -Ta-phenyl(2-hydroxy-5-methylbenzylidene)J -L-lysine (VI).

Na-Boc-L-lysine (741 mg, 3 mmole),
tetramethylammonium hydroxide (2.46 ml/mmole,
3 mmole) and 2-hydroxy-5-methylbenzophenone
(636 mg, 3 mmole) were mixed and diluted with
methanol ( 20 ml).

After leaving over molecular

sieves (3A) for one day, the mixture was worked up
as described in (A). The ethyl acetate-ether
extract yielded 343 mg (78%) of a yellow oil which
was homogeneous on t.l.c Rf 0.76 (chloroform:
methanol:acetic acid= 14:2:1); mass spectrum m/e 396
(MH+-C00H).

The free acid derivative was used

directly without further purification for the
preparation of peptides.

r
Preparation of N 5- |.a-phenyl-(
5-chloro-2-hydroxybenzylidene)]-Na-t-butyloxycarbonyl-L-ornithine
dicyclohexylammonium salt (VII).

Na-Boc-L-ornithine (696 mg, 3 mmole),
tetramethylammonium hydroxide ( 3 mmole) and
5-chloro-2-hydroxybenzophenone (698 mg, 3 mmole)
were mixed and diluted with methanol ( 20 ml).
The reaction mixture was kept over molecular
sieves (3A) until a homogeneous solution resulted.
After removal of the solvent on a rotary evaporator
water (40 ml) was added and the unreacted ketone
was filtered off.

The pH of the solution was then

adjusted to between 5-6 by careful addition of
citric acid solution (20%).

The dried extract

yielded the free acid derivative as a hygroscopic
foam (313 mg, 70%).

vmax^ u3o1^ 3440 cm“1 ,

1690 cm”1 (urethane) , 1720 cm“1(acid) and 1615 cm"1
(imine); mass spectrum m/e 402 (MH+-C00H); t.l.c
Rf 0.69 (chloroform:methanol:acetic acid, 14:2:1).
The free acid was then treated with an equivalent
molar amount of dicyclohexylamine solution (0.40
mmole/ml, 3 mmole) and the solvent was removed on
a rotary evaporator.

The salt crystallized on

standing and was recrystallized from methanol-ether
o

o

Yield 282 mg( 45%); m.p 170-173 C; (a)D+22
(c 4, methanol); Found C, 67.2; H, 8.1; N, 7.0.
^35^50^1^3^>5 re<^u^res C, 66.9; N, 8.0; N, 6.7 %.

Preparation of °N-[q-phenyl-(5-chloro-2-hydroxybenzylidene)]-L-valyl-glycyl-methyl ester (VIII).
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Glycine methyl ester was liberated
from its salt (252 mg, 2 mmole) by dissolving in
aqueous alkali and extracting into ethyl acetate
(20 ml).

The free ester was dissolved in ethyl

acetate (4 ml) and was then treated with N-faphenyl- (5-chloro- 2-hydroxybenzylidene)J-L- valine
(III)(663 mg, 2 mmole).

The mixture was cooled

to 0 C and N,N'-dicyclocarbodiimide (512 mg, 2 mmole)
was added.

After stirring the reaction mixture
©

for one hour at 0 C, the flask was left overnight
in the refrigerator.

The urea by product was then

filtered off and the solution was evaporated.
The residue was taken up in ethyl acetate (80 ml)
and washed in turn with citric acid (20%), water,
sodium bicarbonate (10%) and water.

The dried

solution was evaporated to yield the crude product
which was purified by column chromatography
using gradient elution with benzene-chloroform
mixtures.

The ketimine dipeptide ester was

homogeneous on t.l.c, Rf 0.70 (carbon tetrachloride:
ethyl acetate, 1:1).

The C.I mass spectrum m/e 402

(MH+ ), the infrared spectrum and the melting point
were identical with that of compound (XV)
prepared by the solid phase technique.

- ns Preparation of N-[g-phenyl-(5-chloro-2-hydroxybenzylidene)jf-glycyl-L-phenylalanyl-methyl ester (IX)

Phenylalanine methyl ester hydrochloride
was liberated from its salt (H37 mg, 2 mmole) by
treatment with an equivalent amount of triethylamine
(0.28 ml, 2 mmole).

The free ester derivative was

then treated with N-[a-phenyl-(5-chloro-2-hydroxybenzylidene)]-glycine (I)(580 mg, 2 mmole).

The

reaction mixture was cooled to 0 C and N,N!-dicyclohexylcrarbodiimide

(512 mg, 2 mmole) was added.

o
After stirring at 0 C for one hour, the reaction
mixture was left overnight in the refrigerator.
The urea by product was then filtered off, the
solution was concentrated and the residue was taken
up in ethyl acetate (80 ml).

The organic layer

was washed with citric acid (20%), water, sodium
carbonate (10%) and water.

The dried solution

was crystallized from ether-light petroleum.

The

yield of ketimine dipeptide ester was 230 mg
(51%).

V
3300, 1730 and 1670 cm-1;
max
5
5

C.I mass

spectrum m/e H50 (MH+); t.l.c Rf 0.33 (carbon
.
o
tetrachloride:ethylacetate, 8:2); m.p 97-99 C;
(a)^-16 (c 0.5, methanol); Found C, 66.7; H,5.3
N, 6.3 %.
N, 6.2 %.

C25H23C1N2°4 requires C, 66.6; H, 5.1;
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The use of Ketimine Amino Acichs in Solid Phase
Synthesis.
B.

Attachment

of Ketimine Amino Acids to the

Merrifield Resin.

Preparation of N-|*g-phenyl-(5-chloro-2-hydroxybenzylidene)"!-glycyl-resin (X) .

Merrifield resin ( 1.0 g, 0.98 meq Cl/g
resin) and N-fa-phenyl-(5-chloro-2-hydroxybenzylidene)] -glycine (I)(289 mg, 1 mmole) were
refluxed in ethyl acetate ( 5 ml) in the presence
of triethylamine (0.14 ml, 1 mmole) for forty
eight hours.

The resin was then filtered off and

washed in turn with ethyl acetate, ethanol, water,
methanol and dichloromethane (10 ml).

The

washings were repeated three times for each solvent.
The dried resin was bright yellow in colour.

The

amino acid analysis of the acid hydrolysate of the
resin showed the presence of 0.30 mmole of glycine
per gram of resin.

Preparation of N-[a-phenvl-(5-chloro-2-hydroxybenzylidene)]-L-alanyl-resin (XI).

Using the above procedure (B).

N-[a-

phenyl-(5-chloro-2-hydroxybenzylidene)3 -L-alanine
(260 mg, 1 mmole) was condensed with Merrifield
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resin (1.0 g, 0.98 meq Cl/g resin).

The amino acid

analysis of the product indicated a substitution
of 0.27 mmole alanine/g resin.

Preparation of N- |"a-phenyl-(5-chloro-2-hydroxybenzylidene)] -L-valyl-resin (XII) #

Using the procedure (B).

N-[a-phenyl-

(5-chloro-2-hydroxybenzylidene)J-L-valine (290 mg,
1 mmole) was condensed with Merrifield resin
(1.0 g, 0.98 meqCl/g resin).

The amino acid

analysis of the product indicated a substitution
of 0.32 mmole valine/g resin..

Preparation of N-fot-phenyl-(2-hydroxy-5-methylbenzylidene)j-L-leucyl-resin (XIII).

Using the above procedure (B).

N-£a-

phenyl-(2-hydroxy-5-methylbenzylidene)]-Lleucine (280 mg, 1 mmole) was condensed with
Merrifield resin (1.0 g, 0.98 meq Cl/g resin).
The amino acid analysis of the product indicated
a substitution of

C.

0.2 9nunole leucine/g resin.

General Procedure for the preparation of

Ketimine peptide acyl resins.

i+9
Boc-amino acyl resin (1.0 g, O^O-O.^+O
mmole/g resin) was shaken with trifluoroacetic aciddichloromethane (1:1)(10 ml) for 30 minutes a
reaction flask fitted with a sinter.glass filter and
tap.

The trifluoroacetic acid-dichloromethane

reagent was then removed by filtration and the
resin was washed with dichloromethane (10 ml) and
chloroform (10 ml) (three times).

The resin

was then neutralized by shak ingthe resin with
triethylamine-chloroform (1:9)(10 ml) for 10
minutes.. The resin was then washed with chloroform
(10 ml) and dichloromethane (10 ml)(three times).
The free amino acyl resin was coupled with the
ketimine amino acid derivatives (2.5 mmoles)
in dichloromethane ( *+ ml) and N,N1-dicyclo hexylcarbodiimide (2.5 mmol). After shaking for a further two
hours, the resin was washed three times with
dichloromethane (10 ml), methanol (10 ml) and
dichloromethane (10 ml).

The dry ketimine dipeptide

resin ester was then treated as outlined below.

D.

General procedure for the preparation of

ketimine dipeptide methyl ester.

The ketimine dipeptide resin (0.5 g)
was suspended in anhydrous methanol (20 ml) and
triethylamine (50 mmoles per mmole of peptide).
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The reaction mixture was stirred at room temperature
for twenty four hours.

The resin was filtered

and the filtrate was concentrated.

The residue was

then dissolved in ethyl acetate (20 ml), and the
solution was washed with citric acid (20%, 20 ml)
and water, and the solution was dried and
concentrated.

The transesterification product was

recrystallized using an appropriate solvent.

Preparation of N- fa -phenyl-(5-chloro-2-hydroxybenzylidene)]-L-valyl-glycyl resin ester (XIV) and
methyl ester (XV).

Boc-glycyl resin (1.0 g, 0.35 mmole
glycine/g resin) was deblocked with trifluoroacetic acid :dichloromethane (1:1) for 30 minutes.
The glycyl resin ester was then coupled with
N- fa-phenyl- (5-chloro-2-hydroxybenzylidene)3 -Lvaline (IIIX307.6 mg, 0.875 mmole) as described
in (C).

Transesterification of (XIV) was

achieved by stirring the resin (0.5 g) with
triethylamine (1.23 ml, 8.75 mmole) in methanol
(20 ml), and the solution was washed with citric
acid (20%) and water, and the solution was dried
and concentrated.

The transesterification

product was crystallized from ether-light
petroleum.

Yield 9U mg(67% based on Boc-glycyl-

*

^

.
.

- 51 c

’’

o

resin); m.p 138-139 C; (a)^-23 (c 0.5, methanol);
Vmax3280, 1740, 1650, 1605 cm~^; C.I mass spectrum
m/e 402 (MH+); Rf 0.45 (chloroform).

Found: C, 63.1;

H, 5.9; N, 7.2 %. ^21H 23C^N 2^*+ Teclu^ es C, 62.6;
H, 5.8; N ,7.0 %.

Preparation of N- G -phenyl-5-chloro-2-hydroxybenzylidene)]-gjycyl-L-phenylalanyl resin ester (XVI)
and methyl ester (XVII).

Boc-L-phenylalanyl resin ester (2.0 g,
0.35 mmole phenylalanine/g resin) was deblocked by
a 30 minute treatment with trifluoroacetic acid:
dichloromethane (1:1) at room temperature and a
solution of N- £a-phenyl-(5-chloro-2-hydroxybenzylidene)}-glycine (I)(508 mg, 1,76 mmole) in
dichloromethane (8 ml) was added.

The resin

dipeptide ester was then worked up as described
in (C).

The resin dipeptide ester (XVI)(1.0 g)

was then suspended in methanol (40 ml) containing
triethylamine (2.45 ml, 17.5 mmole).

After

stirring at room temperature for twenty four hours,
the resin was filtered off and the filtrate was
concentrated.

The residue was washed with citric

acid (20%) and water.

After evaporation of the

solvent, the transesterification product was
chromatographed using benzene and benzenechloroform mixture to give the pure dipeptide ester
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(XVII) which was recrystallized from ether light
petroleum.

The compound was identical as shown by

t.l.c Rf 0.33 (carbon tetrachloride:ethyl acetate,
8:2); Vmax (nujol)
. 3300, 1730 and 1670 cm~^;7 C.I
+
Q
mass spectrum m/e 451 (MH ); m.p 97-99 C with
9

compound (IX) prepared by condensation with DCC in
solution.

Hydrolysis and attempted hydrolysis of ketimine
protecting group from N -[q-phenyl-(5-chloro-2hydroxybenzylidene)3 -glycyl-L-phenylalanyl resin
(XVIII) .

(a)

Treatment with 80% acetic acid .
A portion of the resin (XVIII)(0.2 g)

was treated with 80% acetic acid (10 ml).

After

shaking for 24 hours at room temperature, t.l.c
(chloroform) showed only the slightest trace of
ketone in the mother liquor and the colour of the
resin was still bright yellow.

After 72 hours,

the presence of ketone in the solution was no
more pronounced and the resin was still brightly
yellow in colour.

(b)

Treatment with aqueous chloroacetic acid-

dichloromethane reagent.
A further portion of the resin (XVIII)

- 53 (0.2 g) was shaken with dichloromethane-75%
chloroacetic acid (50:37X10 ml).

Although a

significant quantity of ketone was present in the
solution after 6 hours, the resin was still yellow
and its colour was not discharged completely after
a 9 hours reaction period.

(c)

Treatment with hydrochloric acid-tetrahydro-

furan reagent.
A further portion of the resin (XVIII)
(0.2 g) was shaken with 0.U N hydrochloric acid in
tetrahydrofuran (10 ml).

After 30 minutes

treatment, the ketone could be detected in the
mother liquor and after 2% hours the colour had
been completely discharged from the resin.

(d)

Treatment with trifluoroacetic acid:

dichloromethane reagent.
A further portion of the resin (XVIII)
(0.2 g) was treated with trifluoroacetic acid:
dichloromethane (1:1)(10 ml) for 60 minutes at
room temperature.

T.l.c (chloroform) gave no

indication of cleavage of the protecting group.
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(E)

General Procedure for Amino Acid Analysis.

The peptide (approx. 50 nano mole) in
6N HC1 (2.0 ml) was hydrolysed in vacuum at
o
110 C for 24 hours. After evaporation of the
solvent in vacuo, water (1.0 ml) added.

A part

of the hydrolysed residue ( 10 micro litre) was
transferred to a micro reaction vial (0.5 ml
capacity) and a solution of stable isotopically
labelled amino acids (Gly-^N, Ala-D0, Val-Dc
o
b
and Lys^^N) ( 50 nano mole each) was added.
The reaction mixture was evaporated to dryness
under a stream of nitrogen at room temperature.
The residue was the dissolved in anhydrous
methanol (50 micro litre) and acetic anhydride
(10 micro litre) and molecular sieve (3A) was
added.

The vial was capped and the mixture
.
e
was heated at 70 C for 10 minutes. An aliquot
of the reaction mixture (10 micro litre) was
then transferred to a capillary tube and the
solvent was removed under vacuum.
residue was then introduced
spectrometer via

The dried

into the mass

the solid probe inlet system.

- 55 Preparation of Na-t-butyloxycarbonyl-NC-fa-phenyl(2-hydroxy--5-methylbenzylidene)] -L-lysyl-L-valylresin ester (XIX) and methyl ester (XX).

.

Boc-L-valyl resin (2.0 g, 0.32 mmole valine/g
resin) was deblocked with trifluoroacetic acid:
dichloromethane (1:1) (10 ml) for 30 minutes and
.

Cl

c

coupled with N -t-butyloxycarbonyl-N - a-phenyl(2-hydroxy-5-methylbenzylidene) -L-lysine (705 mg,
1.60 mmole) as described in (C).

The protected

dipeptide was removed from the resin (XIX) (0.5 g)
by a twenty four hours treatment with triethylamine
(1.12 ml, 8.0 mmole) and dry methanol (15 ml) at
room temperature.

The reaction mixture was then

filtered, concentrated, and the residue was
dissolved in ethyl acetate ( 10 ml).

’

The organic

layer was then washed with citric acid (20%) and
water and the solvent evaporated.

The residue was

chromatographed on silica using chloroform:
methanol (14:2).

The major fraction gave Na-t-

butyloxyCarbonyl-N -Qx-phenyl-(2-hydroxy-5-methylbenzylidene)J -L-lysyl-L-valyl methyl ester as a
yellow oil which was homogeneous on t.l.c, Rf 0.93
(chloroform:methanol:acetic acid, 14:2:1) and Rf 0.49
(carbon tetrachloride: ethyl acetate, 1:1);
V

(nuiol) 1730, 1670 (broad), 1610 cm-1; C.I

mass spectrum m/e 554 (MH ).
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Preparation of N-t-butyloxycarbonyl-glycyl-glycylN £-[q-phenyl-(2-hydroxy-5-methylbenzylidene)J -Llysyl-L-valyl resin ester (XXI) and methyl ester (XXII)

The protected dipeptyl resin (1,0 g)
was deblocked with a solution of trifluoroacetic
acidrdichloromethane (1:1)(10 ml) and the resin
was then coupled with Boc-glycine (140 mg, 0.80
mmole) as described in (C) to give N-t-butyloxycarbonyl-glycyl-Ne-[a-phenyl-( 2-hydroxy-5-methylbenzylidene)]-L-lysyl-L-valyl-resin ester.
Transesterification of the tripeptide resin ester
will give the protected tripeptide methyl ester.
The Boc protecting group was removed
from the tripeptide resin ester and the resin
was coupled once more with Boc-glycine(140 mg,
0.80 mmole).

After washing the resin with dichloro-

methane (5 x 10 ml) and methanol (3 x 10 ml), a
part of the protected peptide resin (0.5 g) was
treated with triethylamine (1.12 ml, 8.0 mmole)
in methanol (20 ml).

The yellow filtrate was

evaporated to dryness and the residue was then
taken up in ethylacetate (10 ml).

The solution

was washed with citric acid (20%) and water and
the yellow filtrate was chromatographed on silica
using a benzene-methanol mixture and the yellow
y

eluate ^ a s crystallized from ether light petroleum.
The protected tetrapeptide methyl ester (XXII)
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was obtained as a yellow solid (55 mg, 52%); m.p
o

88-90 C; Rf 0.89 (chloroform:methanol:acetic acid,
14:2:1) and Rf 0.55 (carbon tetrachloride:ethyl
acetate, 1:1); C.I mass spectrum m/e 667 (MH+ ).
An amino acid analysis of an acid hydrolysate of
(XXII) yielded glycine 2.08, lysine 0.96 and valine
1 . 00.

Preparation of Na-t-butyloxycarbonyl-Ng:- (q-phenyl(2-hydroxy-5-methylbenzylidene)] -L-lysyl-L-alanylresin ester (XXIII) and methyl ester (XXIV).

Boc-L-alanyl-resin ester (2.0 g, 0.24
mmole/alanine/g resin) was deblocked with
trifluoroacetic acid:dichloromethane (1:1)(10 ml)
for 30 minutes and the resin was then coupled with
the N -t-butyloxycarbonyl-N -£a-phenyl-(2-hydroxy5-methylbenzylidene)J-L-lysine (VI) (528 mg, 1.2
mmole) in dichloromethane (8 ml) as described in
(C).

The protected dipeptide was removed from the

resin (0.5 g)(XXIII) by treatment with triethylamine
(0.84 ml, 6.0 mmole) and dry methanol (15 ml) for
24 hours at room temperature.

The yellow solution

was then filtered from the resin, concentrated,
and the residue was dissolved in ethyl acetate (10 ml)
and washed with citric acid (20%) and water and
dried.

After evaporation of the solvent, the residue
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was chromatographed using chloroform:methanol (14:2).
The major fraction gave I^-t-butyloxycarbonyl-J^fa -phenyl- (2-hydroxy-5 -methylbenzylidene )] -L-ly sy 1L-alany1-methyl ester (38 mg, 60%) as a yellow
oil, homogeneous on t.l.c Rf 0.88 (chloroform:
methanol:acetic acid, 14:2:1) and Rf 0.49 (carbon
tetrachloride :ethyl acetate, 1:1): V

3300, 1740,

1670 and 1610 cm ^ ; C.I mass spectrum m/e 526 (MH+).

Preparation of N-t-butyloxycarbonyl-glycyl-glycylN c- ta-ph,enyl-( 2-hydroxy-5-methylbenzylidene)] -Llysyl-L-alanyl resin ester (XXV) and methyl ester (XXVI)

The protected dipeptyl resin (XXIII)
(1.0 g) was deblocked by a 30 minute treatment with
trifluoroacetic acid:dichloromethane (1:1, 10 ml)
and the resin was coupled as described in (C).
The Boc protecting group was then cleaved with
trifluoroacetic acid in dichloromethane solution
and the resin was coupled once more with Boc-glycine
(105 mg, 0.60 mmole).
up as described in (C).

The resin was then worked
A portion of the protected

peptide was removed from the resin (XXV) (0.5 g)
by transesterification as described in (D) to yield
the protected tetrapeptide methyl ester (XXVI)
which was recrystallized from ether-light petroleum
and was obtained as yellow crystals (35 mg, 45%); ni.p 88 C
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Rf 0.89 (chloroform:methanol:acetic acid, 14:2:1)
and Rf 0.55 (carbon tetrachloride:ethyl acetate,
1:1).

An amino acid analysis of an acid hydrolysate

of (XXVI) yielded glycine 1.98, alanine 0.95 and
lysine 1.00.

Preparation of l^-t-butyloxycarbonyl-N6- fa-phenyl(5-chloro-2-hydroxybenzylidene)]-L-ornithyl-Lalanyl-resin ester (XXVII) and methyl ester (XXVIII).

Boc-L-alanyl resin ester (2.0 g, 0.24
mmole alailine/g resin) was deblocked with
trifluoroacetic acid:dichloromethane (1:1, 10 ml)
and the resin was coupled with an ethyl acetate
oi
6 r
solution of N -t-butyloxycarbonyl-N°-£a-phenyl(5-chloro-2-hydroxybenzylidene)]J -L-ornithine which
was obtained by citric acid acidification of the
corresponding dicyclohexylammonium salt (754 mg,
1.20 mmole) (VII).

Part of the protected dipeptide

was removed from the resin (0.50 g) by
transesterification as described in (D).

The

Na-t-butyloxycarbonyl-N°-fa-phenyl-(5-chloro-2hydroxybenzylidene)]-L-ornithyl-L-alanyl-methyl
ester (XXVIII) (135 mg, 51%) was obtained as a
yellow oil which was homogeneous on t.l.c Rf 0.86
(chloroform,methanol:acetic acid, 14:2:1) and Rf 0.53
(carbon tetrachloride:ethyl acetate, 1:1); and C.I
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mass spectrum m/e 532 (MH+).

Preparation of N-t-butyloxycarbonyl-glycyl-N fa phenyl-(5-chloro-2-hydroxybenzylidene)l -L-ornithylL-alanyl resin ester (XXIX) and methyl ester (XXX)

The protected dipeptide resin (XXVII)
(2.0 g) was deblocked by a 30 minute treatment
with a solution of trifluoroacetic acid¡dichloromethane (1:1) (10 ml) and the resin was coupled
with Boc-glycine (210 mg, 1.20 mmole) as
described in (C).

The protected tripeptide

was removed from the resin (0.5 g) with
triethylamine (1.12 ml) and methanol (20 ml).

’

The resin was filtered off and the yellow
filtrate was evaporated to dryness.

The residue

was taken up in ethyl acetate (10 ml) and washed
with citric acid (20%) and water.

After

evaporation of the solvent, the methyl ester
derivative (XXX) was obtained as a yellow oil.
Yield 35 mg (50%); Rf 0.84 (chloroform¡methanol:
acetic acid= 14:2:1) and Rf 0.46 (carbon tetra
chloride :ethyl acetate, 1:1) and C.I mass spectrum
m/e 589 (MH+ ).

An amino acid analysis of acid

hydrolysate yielded glycine 0.97, alanine 1.0.
Ornithine was not determined.

61
Preparation of N-t-butyloxycarbonyl-glycyl-glycylN -fa -phenyl-(5-chloro-2-hydroxybenzylidene)] -Lornithyl-L-alanyl resin ester (XXXI) and methyl
ester (XXXII).

.

The protected tripeptyl resin (XXIX)
(1.0 g) was deblocked by a 30 minute treatment
with a solution of trifluoroacetic acid :dichloromethane (1:1) (10 ml) and the resin was coupled
once again with Boc-glycine(105 mg, 0.60 mmole).
After washing with dichloromethane (5 x 10 ml)
and methanol (3 x 10 ml), the protected tetra
peptide was removed from the resin by
transesterification with triethylamine (1.12 ml)
and methanol (20 ml).

The resin was filtered'

off and the yellow filtrate was evaporated to
dryness.

The residue was taken up in ethyl

acetate (10 ml) and washed with citric acid
(20%) and water.

After evaporation of the

solvent, the residue was chromatographed using
benzene and benzene-methanol mixtures.

The methyl

ester derivative (XXXII) (HO mg, 51%) was
.
p
obtained as a yellow solid. M.p 92-94 C; t.l.c
Rf 0.84 (chloroform:methanol:acetic acid, 14:2:1)
and Rf 0.51 (carbon tetrachloride :ethyl acetate,
1:1) and mass spectrum m/e 646 (MH+).

An amino

acid analysis.of an acid hydrolysate yielded
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alanine 1.00, glycine 1.96.
determined.

Ornithine was not
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